Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Costs and expenses        
Operating costs $ 2,687 $ 3,564 $ 7,228 $ 7,040
Research and development 330 171 1,101 528
Selling, general and administrative 24,489 2,232 39,372 4,518
Total operating costs and expenses 27,506 5,967 47,701 12,086
Interest expense 1,843 642 5,722 1,827
Change in fair value of warrants (8,369) 0 4,893 1,775
Other income (3) 0 (206) (100)
Total other expense (6,529) 642 10,409 3,502
Net loss $ (20,977) $ (6,609) $ (58,110) $ (15,588)
Loss per share        
Basic (in usd per share) $ (0.18) $ (0.28) $ (0.61) $ (0.75)
Diluted (in usd per share) $ (0.18) $ (0.28) $ (0.61) $ (0.75)
Weighted average common shares        
Basic (in shares) 118,255 27,156 95,773 27,156
Diluted (in shares) 118,255 27,156 95,773 27,156
Other comprehensive loss:        
Unrealized loss on debt securities available for sale $ 89 $ 0 $ (17) $ 0
Total comprehensive loss $ (20,888) $ (6,609) $ (58,127) $ (15,588)